CAR T-Cell Therapy in Lymphoma, Myeloma, and Leukemia – Clinical Updates and Innovations
Request for Credit
Thank you for attending our symposium at the 61st ASH Annual Meeting and Exposition in Orlando! We hope you enjoyed the program.
To obtain your certificate, please select the continue button below. You may also download the slides by clicking on the applicable links.
CAR T-Cell Overview, Trends, Targets, and Rationale
Julie M. Vose, MD, MBA
Download Slides
CAR T-Cell Therapy for Lymphoma: Assessing Multi-Year Response Durability
Frederick Locke, MD
Download Slides
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia: Maximizing Outcomes Through Patient Selection
Bruce Levine, PhD
Download Slides
CAR T-Cell Therapy for Multiple Myeloma: Progress and Promise
David Siegel, MD, PhD
Download Slides
Ongoing Efforts to Improve the Safety of CAR T-Cell Therapy: Cytokine Release Syndrome and Neurotoxicity
Frederick Locke, MD
Download Slides
Emerging Strategies to Enhance CAR T-Cell Therapy Performance: Defined Cell Composition, Dual Target Specificity, and Combination Therapy
Frederick Locke, MD
Download Slides
Request for Credit